Balboni B.; Rinaldi F.; Previtali V.; Ciamarone A.; Girotto S.; Cavalli A., Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies, «CANCERS», 2023, 15, pp. 1817 - 1818 [Scientific article]Open Access
Samuel Harry Myers , Viola Previtali, Laura Poppi, Francesco Rinaldi, Fabrizio Schipani, Jose Antonio Ortega, Francesca De Franco, Marina Veronesi, Roberto Pellicciari, Marinella Roberti, Stefania Girotto, Giuseppina Di Stefano, Andrea Cavalli, Identification and subsequent development of RAD51-BRCA2 disruptors through a fragment-based approach, in: ACS Spring 2022, 2022, pp. 1 - 1 (atti di: ACS Spring 2022, San Diego Convention Center, Room 16A, 20/03/2022) [Abstract]
Previtali V., Myers S. H., Bagnolini G., Poppi L., Rinaldi F., Schipani F., Ortega J. A., De Franco F., Pellicciari R., Girotto S., Oliviero G., Walsh N., Valenti G., Tirelli N., Di Stefano G., Roberti M., Cavalli A., Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer, in: ACS Spring 2022, 2022, pp. 1 - 1 (atti di: ACS Spring 2022, San Diego Convention Center, Room 16A, 20/03/2023) [Abstract]
Schipani, Fabrizio; Manerba, Marcella; Marotta, Roberto; Poppi, Laura; Gennari, Arianna; Rinaldi, Francesco; Armirotti, Andrea; Farabegoli, Fulvia; Roberti, Marinella; Di Stefano, Giuseppina; Rocchia, Walter; Girotto, Stefania; Tirelli, Nicola; Cavalli, Andrea, The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, Article number: 8338 , pp. 1 - 14 [Scientific article]Open Access
Rinaldi F., Schipani F., Scietti L., Girotto S, Cavalli A., Unveiling the molecular mechanism of BRCA2-RAD51 interaction to tackle cancer onset, in: EMBO Practical Course "Characterization of macromolecular complexes by integrative structural biology", 2022(atti di: EMBO Practical Course "Characterization of macromolecular complexes by integrative structural biology", Grenoble, 27/05/2022) [Poster]
Hutmacher C.; Volta L.; Rinaldi F.; Murer P.; Myburgh R.; Manz M.G.; Neri D., Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia, «LEUKEMIA RESEARCH», 2019, 84, Article number: 106178 , pp. 1 - 9 [Scientific article]
